322 related articles for article (PubMed ID: 6206796)
1. [Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion].
Fukuoka M; Takada M; Tamai S; Negoro S; Matsui K; Ryu S; Sakai N; Sakaguchi K
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1543-9. PubMed ID: 6206796
[TBL] [Abstract][Full Text] [Related]
2. Management of malignant pericardial effusion with instillation of mitomycin C in non-small cell lung cancer.
Kaira K; Takise A; Kobayashi G; Utsugi M; Horie T; Mori T; Imai H; Inazawa M; Mori M
Jpn J Clin Oncol; 2005 Feb; 35(2):57-60. PubMed ID: 15709087
[TBL] [Abstract][Full Text] [Related]
3. [Cellular changes in malignant pleural effusion induced by intrapleural injection of BCG-CWS].
Matsuda M; Morishita T; Horai T; Ikegami H; Nakamura S; Nishio H
Gan No Rinsho; 1983 Aug; 29(9):955-61. PubMed ID: 6620573
[TBL] [Abstract][Full Text] [Related]
4. [Immunotherapy of resectable lung cancer using Nocardia rubra cell wall skeleton].
Ogura T
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):366-72. PubMed ID: 6349535
[TBL] [Abstract][Full Text] [Related]
5. [Intrathoracic infusion with a combination of low-dose minocycline, OK-432 and cisplatin for malignant pleural effusion].
Ishimori S; Okada S; Yamagata S; Satoh S
Gan To Kagaku Ryoho; 2005 Mar; 32(3):345-9. PubMed ID: 15791817
[TBL] [Abstract][Full Text] [Related]
6. [State of the art: treatment of malignant pleural and pericardial effusions].
Saka H; Shimokata K
Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():418-25. PubMed ID: 9369917
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled study of adjuvant immunotherapy with Nocardia rubra cell wall skeleton for inoperable lung cancer.
Yamamura Y; Ogura T; Sakatani M; Hirao F; Kishimoto S; Fukuoka M; Takada M; Kawahara M; Furuse K; Kuwahara O
Cancer Res; 1983 Nov; 43(11):5575-9. PubMed ID: 6616485
[TBL] [Abstract][Full Text] [Related]
8. [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].
Watanabe Y; Sato H; Iida S; Yamada T; Kobayashi H; Kimoto H; Tsunamura Y; Ichihashi T; Shimizu J; Hashizume Y
Gan To Kagaku Ryoho; 1985 Jan; 12(1):21-35. PubMed ID: 2981515
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of malignant pleural effusion].
Takada M; Fukuoka M
Gan To Kagaku Ryoho; 1989 Feb; 16(2):165-72. PubMed ID: 2493220
[TBL] [Abstract][Full Text] [Related]
10. [Percutanous trans-catheter intervention for the diagnosis and treatment of malignant pericardial effusion, with a report of 50 cases].
Wu J; Liang S; Zhang Z
Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):221-3. PubMed ID: 9387260
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients].
Shimizu T; Takahashi N; Terakado M; Sato M; Sugane T; Kisohara A; Akusawa H; Tsujino I; Horie T
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1139-43. PubMed ID: 16121916
[TBL] [Abstract][Full Text] [Related]
12. Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primary non-small-cell lung cancer.
Moriya T; Takiguchi Y; Tabeta H; Watanabe R; Kimura H; Nagao K; Kuriyama T
Br J Cancer; 2000 Oct; 83(7):858-62. PubMed ID: 10970685
[TBL] [Abstract][Full Text] [Related]
13. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer.
Ishida A; Miyazawa T; Miyazu Y; Iwamoto Y; Zaima M; Kanoh K; Sumiyoshi H; Doi M
Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of intrapleural administration of pirarubicin (THP-ADM) in the treatment of malignant pleural effusion secondary to lung cancer].
Makimoto T; Hoshino H; Tsuchiya S; Nakano H; Watanabe S; Naruse I; Fueki N; Ezawa K; Takise A; Saitoh R
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31(12):1542-7. PubMed ID: 8121090
[TBL] [Abstract][Full Text] [Related]
15. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.
Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y
Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448
[TBL] [Abstract][Full Text] [Related]
16. [Effect of Nocardia rubra cell wall skeleton against pleuritis carcinomatosa in adenocarcinoma of the lung].
Saijo N; Eguchi K; Tominaga K; Shinkai T; Shimizu E; Shibuya M; Shimabukuro Z; Niitani H
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):290-5. PubMed ID: 6881978
[TBL] [Abstract][Full Text] [Related]
17. [Intrapericardial infusion of etoposide and cisplatin in treating malignant pericardial effusion of non-small cell lung cancer].
Chen LK; Xu GC; Liang Y; Yang QY; Zhang LN
Ai Zheng; 2006 Apr; 25(4):505-8. PubMed ID: 16613690
[TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial of non-specific immunotherapy with cell-wall skeleton of Nocardia rubra.
Yasumoto K; Yamamura Y
Biomed Pharmacother; 1984; 38(1):48-54. PubMed ID: 6380607
[TBL] [Abstract][Full Text] [Related]
19. [Malignant pericardial effusion after esophageal cancer surgery successfully treated by intrapericardial instillation of CDDP].
Murata K; Iwazawa T; Doki Y; Inoue M; Kaneko T; Terashima T; Mizunoya S; Okagawa K
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2433-6. PubMed ID: 2665655
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of intrapleural treatment with aclacinomycin combined with closed tube thoracostomy for malignant pleural effusion].
Fujii M; Okabe K; Toki H; Fujita Y; Ishimitsu T
Gan No Rinsho; 1984 Jul; 30(8):895-8. PubMed ID: 6471394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
